Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.4950
+0.0250 (5.32%)
At close: Mar 17, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 67.06 million as of March 18, 2026. Its market cap has increased by 15.97% in one year.
Market Cap
67.06M
Enterprise Value
57.64M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.50
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 67.06M, an increase of 160.94%. That is a compound annual growth rate of 44.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 67.06M | -19.01% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Epiminder | 151.45M |
| EMVision Medical Devices | 146.84M |
| SomnoMed | 144.17M |
| Compumedics | 60.93M |
| HeraMED | 49.12M |
| Micro-X | 47.20M |
| Nova Eye Medical | 42.73M |
| CleanSpace Holdings | 37.48M |